[1]韩秀娥,张 萍,王雪峰,等.马传染性贫血病毒囊膜基因gp90 V4区糖基化回复突变感染性克隆的构建[J].中国预防兽医学报,2009,(03):165-169.
 HAN Xiu-e,ZHANG Ping,WANG Xue-feng,et al.Construction of an infectious clone within the V4 region of gp90 surface protein of EIAV by N-glycosylation revers-mutations[J].Chinese journal of preventive veterinary medicine,2009,(03):165-169.
点击复制

马传染性贫血病毒囊膜基因gp90 V4区糖基化回复突变感染性克隆的构建
分享到:

《中国预防兽医学报》[ISSN:1008-0589/CN:23-1417/S]

卷:
期数:
2009年03期
页码:
165-169
栏目:
病毒及其病原生物学
出版日期:
2009-03-16

文章信息/Info

Title:
Construction of an infectious clone within the V4 region of gp90 surface protein of EIAV by N-glycosylation revers-mutations
作者:
韩秀娥12张 萍3王雪峰1孔宪刚1周建华1*  相文华1*
1. 中国农业科学院哈尔滨兽医研究所 兽医生物技术国家重点实验室/大动物病研究室,黑龙江 哈尔滨 150001;
2. 东北农业大学黑龙江省乳品工业技术开发中心,黑龙江 哈尔滨 150001;
3. 东北农业大学 动物医学学院,黑龙江 哈尔滨 150001;
Author(s):
HAN Xiu-e12 ZHANG Ping3 WANG Xue-feng1 KONG Xian-gang1 ZHOU Jian-hua 1* XIANG Wen-hua 1*
1. State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of
Agricultural Sciences, Harbin 150001, China; 2. Heilongjiang Dairy Industry Technical Development Center, Northeast Agricultural
University, Harbin 150001, China; 3. College of Veterinary Medicine, Northeast Agricultural University, Harbin 150001, China
关键词:
马传染性贫血病毒N-连接糖基化定点突变感染性克隆
Keywords:
equine infectious anemia virus (EIAV) N-glycosylation site-directed mutagenesis infectious clone
文献标志码:
A
摘要:
为了阐明我国马传染性贫血病毒(EIAV)弱毒疫苗致弱及免疫保护的分子机制,本研究分析了疫苗株及其亲本强毒株共34个囊膜基因序列。结果发现疫苗株在膜基因gp90 V4区潜在的N-连接糖基化位点出现了稳定的碱基替换,使该位点消失。为研究囊膜糖基化的作用,以疫苗株全长感染性克隆pLGFD3-8为亲本,利用反向遗传技术对该突变位点进行了糖基化序列回复突变操作,构建了全基因感染性克隆pLGFDg9。将其转染驴胎皮肤细胞(FDD),通过用逆转录酶活性、间接免疫荧光和RT-PCR方法检测而确定其感染性。结果表明,在FDD细胞中盲传3代后,在细胞培养物中可检测到逆转录酶活性,RT-PCR和间接免疫荧光检测均呈阳性,电镜下见到典型的EIAV颗粒。
Abstract:
The Chinese equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) provides a unique model system for study of the attenuation mechanism and the immunological control of lentivirus replication. In this study, we compared gp90 sequences of the env gene from both virulent and attenuated EIAV strains and found that all attenuated strains lost the potential N-linked glycosylation sites in the V4 region. To determine the action of this mutation, we constructed the infectious clone pLGFDg9 to restore the potential N-linked glycosylation site. This clone was transfected into fetal donkey dermal (FDD) cells and virus replication was monitored by RT-PCR, indirect immune fluorescence and reverse transcriptase activity assay. The results showed that, after 3 passages in FDD cells, virus replication in the cell cultures supernatant was detected by all three methods and viral particles were clearly observed by electron microscopy. The N-glycosylation reverse-mutation infectious clone provides a solid base for further study of the mechanism of attenuation and increased immune protection of EIAV attenuated vaccines.

参考文献/References:

1. Leroux C,Cadorea J,Montellaro RC, et al. Equine infectious anemia virus (EIAV):what has HIV’s country cousin got to tell us? [J]. Vet Res, 2004, 35: 485-512.

2. 于力,张秀芳.慢病毒和相关疾病[M].北京:中国农业科技出版社,1996.

3. Ohgimoto S, T Shioda, K Mori, et al. Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity [J]. J Virol, 1998, 72:8365-8370.

4. Dacheux L, Moreau A, Ataman-Onal Y, et al. Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope [J]. J Virol, 1998, 78, 12625-12637.

5. Wei X, Decker J, Wang S, et al. Antibody neutralization and escape by HIV-1[J]. Nature, 2003, 422, 307-312.

6. Nakowitsch S, Quendler H, Fekete H, et al. HIV-1 mutants escaping neutralization by the human antibodies 2F5,2G12, and 4E10: in vitro experiments versus clinical studies [J]. AIDS, 2005, 19 (17):1957-1966.

7. Chen M, Shi C, Kalia V, et al. HIV gp120 V1/V2 and C2-V3 domains glycoprotein compatibility is required for viral replication [J]. Virus Res, 2001, 79, 91-101.

8. Howe L, Leroux C, Issel C, et al. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype [J]. J Virol, 2002, 76,10588-10597.

9. Johnson W E, Sanford H, Schwall L, et al. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities [J]. J Virol, 2003, 77(18):9993-10003.

10. Ball J M, Swaggerty C L, Pei X, et al. SU proteins from virulent and avirulent EIAV demonstrate distinct biological properties. Virology [J]. 2005,333(1):132-144.

11. Bolmstedt A, Sjolander S, Hansen J E, et al. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J Acquir Immune Defic Syndr Hum Retrovirol [J]. 1996, 12(3):213-220.

相似文献/References:

[1]韩凌霞*,尹岚岚,李亚明,等.EIAV基因转移载体包装盒表达质粒的构建[J].中国预防兽医学报,2009,(03):183.
 HAN Ling-xia*,YIN Lan-lan,LI Ya-ming,et al.Construction of packaging protein expression cassette of gene transfer vector derived from equine infectious anemia virus [J].Chinese journal of preventive veterinary medicine,2009,(03):183.
[2]张 萍*,于在江,韩秀娥,等.马传染性贫血病毒基质蛋白p15单克隆抗体的制备 [J].中国预防兽医学报,2009,(09):730.
 ZHANG Ping,*,YU Zai-jiang,et al.Preparation of monoclonal antibodies against the matrix protein of equine infectious anemia virus [J].Chinese journal of preventive veterinary medicine,2009,(03):730.
[3]高 旭,姜成刚,高 华,等.马传染性贫血病毒疫苗株S2基因不同变异位点逆向突变感染性克隆的体外复制特性分析[J].中国预防兽医学报,2009,(12):919.
 GAO Xu,JIANG Cheng-gang,GAO Hua,et al.In vitro replication analysis of infectious clones of the Chinese attenuated infectious anemia virus vaccine strain reverse-mutated in the S2 gene [J].Chinese journal of preventive veterinary medicine,2009,(03):919.
[4]耿庆华#,郭 巍#,赵立平,等.S2基因失活突变马传染性贫血病毒感染性克隆的构建及感染性研究[J].中国预防兽医学报,2010,(07):499.
 GENG Qing-hua,GUO Wei,ZHAO Li-ping,et al.Construction of EIAV infectious clone with S2 gene dominant negative mutation[J].Chinese journal of preventive veterinary medicine,2010,(03):499.
[5]姜成刚,马建,林跃智,等.通过暂时免疫抑制研究跨膜蛋白C 末端缺失对EIAV 疫苗株EIAVFDDV12体内复制的影响[J].中国预防兽医学报,2010,(11):829.[doi:10.3969/j.issn.1008-0589.2010.11.01]
 JIANG Cheng-gang,MA Jian,LIN Yue-zhi,et al.Transient immunesuppression of inapparent carriers infected with live attenuated equine infectious anemia virus vaccine clone[J].Chinese journal of preventive veterinary medicine,2010,(03):829.[doi:10.3969/j.issn.1008-0589.2010.11.01]
[6]王雪峰,杨 彬,韩秀娥,等.马传染性贫血病毒驴白细胞弱毒疫苗株致弱过程中不同代次病毒LTR的进化分析[J].中国预防兽医学报,2010,(12):915.[doi:doi: 10.3969/j.issn.1008-0589.2010.12.01]
 WANG Xue-feng,YANG Bin,HAN Xiu-e,et al.Genetic evolution of equine infectious anemia virus LTR region during attenuation in vitro[J].Chinese journal of preventive veterinary medicine,2010,(03):915.[doi:doi: 10.3969/j.issn.1008-0589.2010.12.01]
[7]全滟平,沈 楠,郭 巍,等.马传染性贫血病毒LTR在驴胎皮肤细胞中的基因进化及启动子活性比较[J].中国预防兽医学报,2008,(07):510.
 QUAN Yan-ping,SHEN Nan,GUO Wei,et al.Evolution of equine infectious anemia virus LTRs during passage in the fetal donkey dermal cell[J].Chinese journal of preventive veterinary medicine,2008,(03):510.
[8]尹岚岚,韩凌霞*,李亚明,等.EIAV基因转移载体的优化[J].中国预防兽医学报,2008,(03):183.
 YIN Lan-lan,HAN Ling-xia*,LI Ya-ming,et al.Improvement of gene transfer vector derived from equine infectious anemia virus[J].Chinese journal of preventive veterinary medicine,2008,(03):183.
[9]左咏梅,吕晓玲,赵立平,等.马传染性贫血病毒弱毒株LTR点突变型嵌合感染性克隆的构建[J].中国预防兽医学报,2007,(08):569.
 ZUO Yong-mei,LV Xiao-ling,ZHAO Li-ping,et al.Construction of a chimeric clone of Chinese equine infectious anemia virus by site-mutation in the LTR region[J].Chinese journal of preventive veterinary medicine,2007,(03):569.
[10]王雪峰,王 帅,韩秀娥,等.马传染性贫血弱毒疫苗株致弱过程中表面蛋白gp90的进化分析[J].中国预防兽医学报,2011,(02):93.[doi:10.3969/j.issn.1008-0589.2011.02.03]
 WANG Xue-feng,WANG Shuai,HAN Xiu-e,et al.Genetic evolution of the equine infectious anemia vaccine strain gp90 gene during attenuation process[J].Chinese journal of preventive veterinary medicine,2011,(03):93.[doi:10.3969/j.issn.1008-0589.2011.02.03]

备注/Memo

备注/Memo:

收稿日期:2008-10-19

基金项目:国家“973项目” (2001CCA00600);黑龙江省发展高新技术产业专项资金项目(FW05B007)

作者简介:韩秀娥(1978-),女,黑龙江省佳木斯人,助理研究员,研究方向为病毒分子生物学与免疫学.

通信作者: E-mal:xiangwenhua1@yahoo.com

更新日期/Last Update: 2009-03-23